Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a neurodegenerative condition characterized by chronic inflammation. Nuclear factorκB (NF-κB) is a family of inducible transcription factors that are expressed in a wide variety of cells and tissues, including microglia, astrocytes, and neurons, and the classical NF-κB pathway plays a key role in the activation and regulation of inflammatory mediator production during inflammation. Activation of the classical NF-κB pathway is mediated through the activity of the IKK kinase complex, which consists of a heterotrimer of IKKα, IKKβ, and IKKγsubunits. Targeting NF-κB has been proposed as an approach to the treatment of acute and chronic inflammatory conditions, and the use of inhibitors specific for either IKKβor IKKγhas now been found to inhibit neurodegeneration of TH+ DA-producing neurons in murine and primate models of Parkinson's disease. These studies suggest that targeting the classical pathway of NF-κB through the inhibition of the IKK complex can serve as a useful therapeutic approach to the treatment of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918 · cited 1×
“NFκB subsequently plays an essential role in the inflammatory response through regulation of genes encoding inflammatory cytokines (IL-1β, TNFα, IL-12/23), chemokines (IL-8, MIP-1α, MCP-1 [38–40]), nitric oxide production (iNOS), NADPH oxidase subunits p47 and p67 [41, 42], and adhesion molecules (ICAM-1, VCAM, and E-…”
BackgroundMcGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858 · cited 5×
“Activated microglial cells then secrete these inflammatory cytokines, such as TNF-α, IL-1β, MIP1α, and IL-6 [25], which can both recruit new inflammatory cells as well as lead to direct killing of DA neurons.”
BackgroundInfluentialMicroglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Self-citationMogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855 · cited 3×
“Highly elevated levels of several of these inflammatory mediators (TNF, NO, PGE2, IL-1β, IL-6) can be found in the cerebrospinal fluid (CSF) of PD patients, as well as in the brain SNpc tissue of PD patients when analyzed in postmortem autopsies [7, 9, 10, 27, 32, 33].”
BackgroundImamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · cited 1×
“Highly elevated levels of several of these inflammatory mediators (TNF, NO, PGE2, IL-1β, IL-6) can be found in the cerebrospinal fluid (CSF) of PD patients, as well as in the brain SNpc tissue of PD patients when analyzed in postmortem autopsies [7, 9, 10, 27, 32, 33].”
BackgroundNitric oxide synthase and neuronal vulnerability in parkinson's disease
Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595 · cited 2×
“Highly elevated levels of several of these inflammatory mediators (TNF, NO, PGE2, IL-1β, IL-6) can be found in the cerebrospinal fluid (CSF) of PD patients, as well as in the brain SNpc tissue of PD patients when analyzed in postmortem autopsies [7, 9, 10, 27, 32, 33].”
BackgroundSevere liver degeneration and lack of NF-κ B activation in NEMO/IKKγ-deficient mice
Rudolph, D., Yeh, W.-C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A. J., & Mak, T. W. (2000) · Genes & Development · doi:10.1101/gad.14.7.854 · Cited by 479
Cited by
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.014 · Cited by 2,162
Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Pajares, M., I. Rojo, A., Manda, G., Boscá, L., & Cuadrado, A. (2020) · Cells · doi:10.3390/cells9071687 · Cited by 779
Sivandzade, F., Prasad, S., Bhalerao, A., & Cucullo, L. (2019) · Redox Biology · doi:10.1016/j.redox.2018.11.017 · Cited by 639
Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity
Gao, W., Guo, L., Yang, Y., Wang, Y., Xia, S., Gong, H., Zhang, B.-K., & Yan, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809952 · Cited by 320
Microglial phenotypes in Parkinson’s disease and animal models of the disease
Joers, V., Tansey, M. G., Mulas, G., & Carta, A. R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.006 · Cited by 285
“…in PD (Ghosh et al., 2007; Glass et al., 2010; Hunot et al., 1997; Mogi et al., 2007), while inhibition of the NFκB pathway has been shown to confer neuroprotection in animal models of PD by dampening inflammatory responses (Flood et al., 2011; Ghosh et al., 2007; Tran et al., 2008).”
BackgroundMitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling
Dutta, K., Thammisetty, S. S., Boutej, H., Bareil, C., & Julien, J.-P. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0536-20.2020 · Cited by 55
“…as cerebral ischemia and traumatic brain injury (Harari and Liao, 2010) as well as chronic neurodegenerative disorders, such as Alzheimer’s disease (Jones and Kounatidis, 2017), Parkinson’s disease (Flood et al., 2011), Huntington’s disease (Bečanovi c et al., 2015), and ALS (Sako et al., 2012).”
BackgroundYurtsever, İ., Üstündağ, Ü. V., Ünal, İ., Ateş, P. S., & Emekli-Alturfan, E. (2022) · Drug and Chemical Toxicology · doi:10.1080/01480545.2020.1846549 · Cited by 39
“Inflammatory cytokines secreted from activated microglial cells include TNF-a, IL-1, and IL-6, which can lead to direct killing of DA neurons (Flood et al. 2011).”
BackgroundMitra, S., Ghosh, N., Sinha, P., Chakrabarti, N., & Bhattacharyya, A. (2015) · Scientific Reports · doi:10.1038/srep13949 · Cited by 11
Pluripotential GluN1 (NMDA NR1): Functional Significance in Cellular Nuclei in Pain/Nociception
McNearney, T. A., & Westlund, K. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713196 · Cited by 9
Metadata
- Authors
- Flood, P. M., Qian, L., Peterson, L. J., Zhang, F., Shi, J.-S., Gao, H.-M., & Hong, J.-S.
- Venue
- Parkinson's Disease
- Publisher
- Wiley
- Published
- 2011
- Volume
- 2011
- Pages
- 1-8
- ISSN
- 2042-0080 (ISSN-L)
- OpenAlex
- W1986288479
- Cited by
- 102
- References
- 15
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.